SWOG clinical trial number
SWOG-9015
A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III
Closed
Phase
Accrual
5%
Abbreviated Title
A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III
Activated
05/15/1992
Closed
03/15/1994
Research committees
Lung Cancer
Publication Information Expand/Collapse
2014
PMid: PMID24576776 | PMC number: PMC4022989
Other Clinical Trials
SWOG Clinical Trial Number
S2302
PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
68%
Open
Phase
SWOG Clinical Trial Number
A082002
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007
RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open